NcRNAs-mediated High Expression of SEMA3F Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma

Overview

Journal Mol Ther Nucleic Acids

Publisher Cell Press

Date 2021 May 24

PMID 34026328

Citations 37

Authors

Weiyang Lou

Wenlong Wang

Jing Chen

Shuqian Wang

Yuan Huang

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) is notorious for its poor prognosis. Increasing evidence has demonstrated that semaphorin 3F (SEMA3F) plays key roles in initiation and progression of several types of human cancer. However, the specific role and mechanism of SEMA3F in HCC remains not fully determined. In this study, we first performed pan-cancer analysis for SEMA3F's expression and prognosis using The Cancer Genome Atlas (TCGA) and The Genotype-Tissue Expression (GTEx) data and found that SEMA3F might be a potential oncogene in HCC. Subsequently, noncoding RNAs (ncRNAs) contributing to SEMA3F overexpression were identified by a combination of a series of analyses, including expression analysis, correlation analysis, and survival analysis. Finally, the TMPO-AS1/SNHG16-let-7c-5p axis was identified as the most potential upstream ncRNA-related pathway of SEMA3F in HCC. Moreover, SEMA3F level was significantly positively associated with tumor immune cell infiltration, biomarkers of immune cells, and immune checkpoint expression. Collectively, our findings elucidated that ncRNAs-mediated upregulation of SEMA3F correlated with poor prognosis and tumor immune infiltration in HCC.

Citing Articles

Molecular mechanisms underlying roles of long non-coding RNA small nucleolar RNA host gene 16 in digestive system cancers.

Yang T, Li X, Kong M World J Gastrointest Oncol. 2024; 16(11):4300-4308.

PMID: 39554746 PMC: 11551640. DOI: 10.4251/wjgo.v16.i11.4300.

Semaphorin 3F (SEMA3F) influences patient survival in esophageal adenocarcinoma.

Knipper K, Lyu S, Jung J, Alich N, Popp F, Schroder W Sci Rep. 2024; 14(1):20589.

PMID: 39232098 PMC: 11375056. DOI: 10.1038/s41598-024-71616-8.

The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma.

Moragas N, Fernandez-Nogueira P, Recalde-Percaz L, Inman J, Lopez-Plana A, Bergholtz H Breast Cancer Res. 2024; 26(1):122.

PMID: 39138514 PMC: 11320849. DOI: 10.1186/s13058-024-01871-0.

Roles of long non‑coding RNA SNHG16 in human digestive system cancer (Review).

Zhao L, Kan Y, Wang L, Pan J, Li Y, Zhu H Oncol Rep. 2024; 52(2).

PMID: 38940337 PMC: 11234248. DOI: 10.3892/or.2024.8765.

Circulating GDF-15: a biomarker for metabolic dysregulation and aging in people living with HIV.

Wang L, Zhao J, Schank M, Hill A, Banik P, Zhang Y Front Aging. 2024; 5():1414866.

PMID: 38895099 PMC: 11183798. DOI: 10.3389/fragi.2024.1414866.

References

Jing Z, Ye X, Ma X, Hu X, Yang W, Shi J . SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma. Cancer Med. 2020; 9(12):4324-4338. PMC: 7300419. DOI: 10.1002/cam4.3020. View

Chen H, Li M, Huang P . LncRNA SNHG16 Promotes Hepatocellular Carcinoma Proliferation, Migration and Invasion by Regulating miR-186 Expression. J Cancer. 2019; 10(15):3571-3581. PMC: 6603422. DOI: 10.7150/jca.28428. View

Plant T, Eamsamarng S, A Sanchez-Garcia M, Reyes L, Renshaw S, Coelho P . Semaphorin 3F signaling actively retains neutrophils at sites of inflammation. J Clin Invest. 2020; 130(6):3221-3237. PMC: 7259996. DOI: 10.1172/JCI130834. View

Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi P . A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell. 2011; 146(3):353-8. PMC: 3235919. DOI: 10.1016/j.cell.2011.07.014. View

Jin B, Wang W, Meng X, Du G, Li J, Zhang S . Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway. BMC Cancer. 2016; 16(1):863. PMC: 5100284. DOI: 10.1186/s12885-016-2904-y. View

Kieszkowski P, Dabrus D, Grabarek B, Boron D . Differences in the Expression Pattern of mRNA Protein SEMA3F in Endometrial Cancer under Cisplatin Treatment. Curr Pharm Biotechnol. 2020; 21(11):1119-1128. PMC: 7536788. DOI: 10.2174/1389201021666200416102540. View

Dziobek K, Oplawski M, Grabarek B, Zmarzly N, Kielbasinski R, Lesniak E . Changes in Expression Pattern of SEMA3F Depending on Endometrial Cancer Grade - Pilot Study. Curr Pharm Biotechnol. 2019; 20(9):727-732. PMC: 7046987. DOI: 10.2174/1389201020666190619145655. View

Lou W, Liu J, Ding B, Chen D, Xu L, Ding J . Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC. J Transl Med. 2019; 17(1):7. PMC: 6317219. DOI: 10.1186/s12967-018-1761-7. View

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

10.

Luo Z, Lu L, Tang Q, Wei W, Chen P, Chen Y . CircCAMSAP1 promotes hepatocellular carcinoma progression through miR-1294/GRAMD1A pathway. J Cell Mol Med. 2021; 25(8):3793-3802. PMC: 8051675. DOI: 10.1111/jcmm.16254. View

11.

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

12.

Zhang J, Chen J, Hua L, Yao K, Wang C . miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/β-catenin signaling pathway. Biomed Pharmacother. 2016; 85:472-478. DOI: 10.1016/j.biopha.2016.11.053. View

13.

Lyu L, Yao J, Wang M, Zheng Y, Xu P, Wang S . Overexpressed Pseudogene Promotes Tumor Immune Infiltrates by Regulating and Indicates a Better Prognosis in Breast Cancer. Front Oncol. 2020; 10:1245. PMC: 7438735. DOI: 10.3389/fonc.2020.01245. View

14.

Waniczek D, Lorenc Z, Snietura M, Wesecki M, Kopec A, Muc-Wierzgon M . Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer. Arch Immunol Ther Exp (Warsz). 2017; 65(5):445-454. PMC: 5602054. DOI: 10.1007/s00005-017-0463-9. View

15.

Smyth G, Michaud J, Scott H . Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics. 2005; 21(9):2067-75. DOI: 10.1093/bioinformatics/bti270. View

16.

Xie X, Xu X, Sun C, Yu Z . Long intergenic noncoding RNA SNHG16 interacts with miR-195 to promote proliferation, invasion and tumorigenesis in hepatocellular carcinoma. Exp Cell Res. 2019; 383(1):111501. DOI: 10.1016/j.yexcr.2019.111501. View

17.

Chae Y, Arya A, Iams W, Cruz M, Chandra S, Choi J . Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC). J Immunother Cancer. 2018; 6(1):39. PMC: 5956851. DOI: 10.1186/s40425-018-0349-3. View

18.

Liu Y, Li R, Yin K, Ren G, Zhang Y . The crucial role of SEMA3F in suppressing the progression of oral squamous cell carcinoma. Cell Mol Biol Lett. 2018; 22:32. PMC: 5745788. DOI: 10.1186/s11658-017-0064-y. View

19.

Ding B, Lou W, Liu J, Li R, Chen J, Fan W . In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC. Cancer Cell Int. 2019; 19:186. PMC: 6637578. DOI: 10.1186/s12935-019-0901-3. View

20.

Gao S, Ding B, Lou W . microRNA-Dependent Modulation of Genes Contributes to ESR1's Effect on ERα Positive Breast Cancer. Front Oncol. 2020; 10:753. PMC: 7243797. DOI: 10.3389/fonc.2020.00753. View